AI Verdict
ENDI has stronger fundamentals based on our AI analysis.
ENDV vs ENDI Fundamental Comparison
| Metric | ENDV | ENDI |
|---|---|---|
| Revenue | $134,260.0 | $9.6M |
| Net Income | $8.5M | $2.5M |
| Net Margin | 6,351.8% | 26.4% |
| ROE | N/A | 10.9% |
| ROA | 1,045.4% | 9.9% |
| Current Ratio | 0.00x | 14.42x |
| Debt/Equity | N/A | 0.00x |
| EPS | $0.00 | $0.46 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ENDV vs ENDI: Frequently Asked Questions
Is ENDV or ENDI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ENDI has stronger fundamentals. ENDV is rated STRONG SELL (95% confidence) while ENDI is rated BUY (72% confidence). This is not investment advice.
How does ENDV compare to ENDI fundamentally?
ENDONOVO THERAPEUTICS, INC. has ROE of N/A vs ENDI Corp.'s 10.9%. Net margins are 6,351.8% vs 26.4% respectively.
Which stock pays higher dividends, ENDV or ENDI?
ENDV has a dividend yield of N/A or no dividend while ENDI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ENDV or ENDI for long term?
For long-term investing, consider that ENDV has STRONG SELL rating with 95% confidence, while ENDI has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ENDV vs ENDI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ENDV vs ENDI, the AI consensus favors ENDI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.